通过PINK1/帕金介导的线粒细胞灭绝途径,CREG1减轻了骨关节炎的进展
Xianming Fei1, Shuanggong Liu2, Guangxu Song2
1Department of Orthopaedics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
Biotechnology journal
|February 16, 2026
概括
E1A刺激基因1 (CREG1) 的细胞抑制剂通过降低状细胞烧灭来防止骨关节炎 (OA). CREG1增强了线粒体和线粒体功能,为OA提供了潜在的治疗点.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 骨关节炎 (OA) 是一种退行性关节疾病,在这种疾病中,由NLRP3炎症体介导的状细胞灭是进展的关键驱动因素.
- E1A刺激基因1 (CREG1) 的细胞抑制剂,一种调节细胞平衡的葡萄糖蛋白,在OA病变发生过程中起着未被描述的作用.
研究的目的:
- 研究CREG1在骨关节炎中的作用和分子机制.
- 为了确定CREG1是否影响NLRP3炎症酶介导的冠状细胞烧灭.
主要方法:
- 对人体OA软骨的分析,以将CREG1表达与状细胞烧灭相关联.
- 使用一个体外模型的LPS/ATP诱导的状细胞灭,以评估CREG1对灭,细胞外基质 (ECM) 降解,NLRP3炎症酶激活和线粒细胞衰变 (PINK1/帕金依赖) 的影响.
- 采用环素A (CsA) 抑制甲状腺和评估其影响.
主要成果:
- 在OA软骨中,CREG1表达显著下降,与状细胞烧灭相反相关.
- 沉默CREG1加剧了亡,ECM降解,NLRP3炎症酶激活,并损害了线粒体和线粒体功能.
- 过度表达CREG1可以通过恢复线粒,改善线粒体平衡,抑制NLRP3炎症酶激活来逆转这些有害影响,而这些效应被CsA阻.
结论:
- 克雷格1通过抑制NLRP3炎症酶驱动的状细胞灭作用,作为一种防止OA进展的保护因子.
- CREG1通过激活PINK1/帕金因依赖性线粒来实现这种保护.
- 在骨关节炎治疗中,CREG1是一个有前途的治疗点.
相关概念视频
02:58Regulated Protein Degradation
8.9K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.9K
02:58Regulated Protein Degradation
3.2K
3.2K
01:22PI3K/mTOR/AKT Signaling Pathway
5.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.7K
01:31The Intrinsic Apoptotic Pathway
8.7K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.7K
01:16TGF - β Signaling Pathway
10.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.6K
01:20The JAK-STAT Signaling Pathway
13.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.1K